Nuclear medicine creating travel problems

Researchers were unable to find a significant benefit for patients for the majority of cancer medications given accelerated FDA approval.

Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.

A Q&A with Douglas Hoey, CEO of NCPA, on how the new provision from CMS requiring DIR fees at the point of sale is impacting independent pharmacies in 2024.

Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.

With an unprecedented number of Americans in need of mental health care, what role should pharmacists play when it comes to screenings?

With the judge’s failure to approve a settlement class, a $13.5 million settlement against Eli Lilly was called off.